# Clinical Study of JS007 in Patients With Advanced Solid Tumors

> **NCT05049265** · PHASE1 · UNKNOWN · sponsor: **Shanghai Junshi Bioscience Co., Ltd.** · enrollment: 42 (estimated)

## Conditions studied

- Patients With Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** JS007

## Key facts

- **NCT ID:** NCT05049265
- **Lead sponsor:** Shanghai Junshi Bioscience Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-17
- **Primary completion:** 2022-09-20
- **Final completion:** 2022-09-20
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2021-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05049265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05049265, "Clinical Study of JS007 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05049265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*